Prestige Consumer Healthcare, Inc. (PBH)
52.01
+0.70
(+1.36%)
USD |
NYSE |
Aug 24, 16:00
52.01
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Enterprise Value : 4.409B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 4.409B |
| August 20, 2026 | 4.372B |
| August 19, 2026 | 4.426B |
| August 18, 2026 | 4.374B |
| August 17, 2026 | 4.349B |
| August 14, 2026 | 4.412B |
| August 13, 2026 | 4.409B |
| August 12, 2026 | 4.454B |
| August 11, 2026 | 4.517B |
| August 10, 2026 | 4.489B |
| August 07, 2026 | 4.577B |
| August 06, 2026 | 4.557B |
| August 05, 2026 | 4.488B |
| August 04, 2026 | 4.442B |
| August 03, 2026 | 4.438B |
| July 31, 2026 | 4.357B |
| July 30, 2026 | 4.345B |
| July 29, 2026 | 4.451B |
| July 28, 2026 | 4.428B |
| July 27, 2026 | 4.366B |
| July 24, 2026 | 4.331B |
| July 23, 2026 | 4.297B |
| July 22, 2026 | 4.300B |
| July 21, 2026 | 4.301B |
| July 20, 2026 | 4.366B |
| Date | Value |
|---|---|
| July 17, 2026 | 4.343B |
| July 16, 2026 | 4.375B |
| July 15, 2026 | 4.269B |
| July 14, 2026 | 4.214B |
| July 13, 2026 | 4.291B |
| July 10, 2026 | 4.295B |
| July 09, 2026 | 4.275B |
| July 08, 2026 | 4.266B |
| July 07, 2026 | 4.367B |
| July 06, 2026 | 4.293B |
| July 02, 2026 | 4.319B |
| July 01, 2026 | 4.260B |
| June 30, 2026 | 4.218B |
| June 29, 2026 | 3.254B |
| June 26, 2026 | 3.320B |
| June 25, 2026 | 3.214B |
| June 24, 2026 | 3.221B |
| June 23, 2026 | 3.161B |
| June 22, 2026 | 3.133B |
| June 18, 2026 | 3.204B |
| June 17, 2026 | 3.165B |
| June 16, 2026 | 3.229B |
| June 15, 2026 | 3.190B |
| June 12, 2026 | 3.244B |
| June 11, 2026 | 3.233B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Indivior Pharmaceuticals, Inc. | 4.638B |
| ANI Pharmaceuticals, Inc. | 1.966B |
| Corcept Therapeutics, Inc. | 12.89B |
| Veru, Inc. | 21.90M |
| Johnson & Johnson | 679.08B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 29.18M |
| Revenue (Quarterly) | 265.71M |
| Total Expenses (Quarterly) | 236.53M |
| EPS Diluted (Quarterly) | 0.6129 |
| Gross Profit Margin (Quarterly) | 49.11% |
| Profit Margin (Quarterly) | 10.98% |
| Earnings Yield | 6.87% |
| Operating Earnings Yield | 11.58% |
| Normalized Earnings Yield | 6.867 |